PanTera, a Belgian radioisotope producer, announced today (11 September) that it had secured €93m ($102.4m) in an ...

Belgium-based PanTera has raised €134 million in a Series A funding round led by EQT Life Sciences to accelerate the ...

A drug which has changed the lives of patients with end-stage prostate cancer is no longer available at Inkosi Albert Luthuli ...

For developers and businesses looking to integrate the powerful capabilities of Claude AI into their applications, obtaining ...

Belgium-based PanTera has raised €134 million in a Series A funding round led by EQT Life Sciences to accelerate the large-scale production of actinium-225 (225Ac), a crucial isotope for Targeted ...

Novartis' Pluvicto is expected to dominate the market for radioligand therapies for prostate cancer, with ...

With fresh, positive data in hand, Biohaven now believes its medicine could be the first to receive FDA approval for spinocerebellar ataxia.

OpenAI just unveiled a new program, OpenAI Academy, to help "developers and organizations leverage AI to solve hard problems ...

The API revolution wasn’t televised. Now, enterprises must figure out how to weave together a patchwork of API styles, ...

Runway, one of several AI startups developing video-generating tech, today announced an API to allow devs and organizations ...

IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, is pleased to share the below press release from its joint venture PanTera, which is focussed on the production of ...